Affordable Access

Booster vaccination of toddlers with reduced antigen content diphtheria-tetanus-acellular pertussis vaccine

  • Nolan, Terry
  • Ruff, Tilman A.
  • Lambert, Stephen B.
  • Buttery, Jim
  • O'Grady, Kerry-Ann
  • Streeton, Catherine
  • Hoet, Bernard
  • Bock, Hans L.
Publication Date
Jan 01, 2009
Queensland University of Technology ePrints Archive
External links


Immunogenicity and reactogenicity of DTPa and reduced antigen dTpa booster vaccines were compared to a hepatitis A control vaccine in DTPa-primed toddlers aged 18-20 months. Post-booster, all DTPa and dTpa recipients were seroprotected against diphtheria and tetanus, and >= 93.3% had a booster response to pertussis. There were similar reactogenicity rates in the DTPa and dTpa vaccine recipients. Few Grade 3 symptoms were reported. Just over one in four children in the control group had diphtheria antibody at or potentially below the correlate of protection benchmark (0.016 IU/ml). Larger studies should evaluate potential benefits of reduced antigen vaccines and seroprotection in children who do not receive a booster dose of DTPa at this age, including protection against diphtheria until subsequent booster doses are given. (C) 2009 Elsevier Ltd. All rights reserved.

Report this publication


Seen <100 times